Quick Answer
Cardio Diagnostics Holdings, Inc. reported Diluted EPS of $3.71 per share (loss) for fiscal year 2025.
Cardio Diagnostics Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.71 | +60.3% |
| 2024 | -$9.35 | -1316.7% |
| 2023 | -$0.66 | +56.3% |
| 2022 | -$1.51 | -184.9% |
| 2021 | -$0.53 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.98 | +43.4% | -1.0% |
| June 30, 2025 | -$0.97 | +43.3% | +0.0% |
| March 31, 2025 | -$0.97 | +83.6% | +43.9% |
| September 30, 2024 | -$1.73 | -981.2% | -1.2% |
| June 30, 2024 | -$1.71 | -338.5% | +71.2% |
| March 31, 2024 | -$5.93 | -5290.9% | -3606.2% |
| September 30, 2023 | -$0.16 | +5.9% | +59.0% |
| June 30, 2023 | -$0.39 | -143.8% | -254.5% |
- Cardio Diagnostics Holdings, Inc. showed an increase of +60.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Cardio Diagnostics Holdings, Inc.’s diluted eps has declined by 600.0% (from $0.53 per share (loss) to $3.71 per share (loss)).
- The most recent figure is from Cardio Diagnostics Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: